The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1743, Issue 1-2, 2005, Pages 79-85

  Wang, Jian ^a   Pantopoulos, Kostas ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Ferritin; Iron regulatory protein; Iron responsive element; Transferrin receptor

Indexed keywords

2 OXOGLUTARATE DEPENDENT OXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; IRON REGULATORY PROTEIN 2; ISOENZYME; OXYGEN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IRON METABOLISM; IRON RESPONSIVE ELEMENT; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 15044360562     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2004.08.011     Document Type: Article

References (25)

1. R.S. Eisenstein Iron regulatory proteins and the molecular control of mammalian iron metabolism Annu. Rev. Nutr. 20 2000 627 662
2. G. Cairo, and A. Pietrangelo Iron regulatory proteins in pathobiology Biochem. J. 352 2000 241 250
3. T. LaVaute, S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S.K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer III, A. Grinberg, P. Love, N. Tresser, and T.A. Rouault Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice Nat. Genet. 27 2001 209 214
4. B. Guo, J.D. Phillips, Y. Yu, and E.A. Leibold Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome J. Biol. Chem. 270 1995 21645 21651
5. E.S. Hanson, L.M. Foot, and E.A. Leibold Hypoxia post-translationally activates iron-regulatory protein 2 J. Biol. Chem. 274 1999 5047 5052
6. K. Iwai, R.D. Klausner, and T.A. Rouault Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2 EMBO J. 14 1995 5350 5357
7. K. Iwai, S.K. Drake, N.B. Wehr, A.M. Weissman, T. LaVaute, N. Minato, R.D. Klausner, R.L. Levine, and T.A. Rouault Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins Proc. Natl. Acad. Sci. U. S. A. 95 1998 4924 4928
8. J. Wang, G. Chen, M. Muckenthaler, B. Galy, M.W. Hentze, and K. Pantopoulos Iron-mediated degradation of IRP2: an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity Mol. Cell. Biol. 24 2004 954 965
9. E.S. Hanson, M.L. Rawlins, and E.A. Leibold Oxygen and iron regulation of iron regulatory protein 2 J. Biol. Chem. 278 2003 40337 40342
10. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein EMBO J. 19 2000 4298 4309
11. K. Guillemin, and M.A. Krasnow The hypoxic response: huffing and HIFing Cell 89 1997 9 12
12. 2 homeostasis Curr. Opin. Genet. Dev. 8 1998 588 594
13. N. Masson, C. Willam, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation EMBO J. 20 2001 5197 5206
14. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R.M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
15. 2 sensing Science 292 2001 464 468
16. 2-regulated prolyl hydroxylation Science 292 2001 468 472
17. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
18. C.J. Schofield, and Z. Zhang Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes Curr. Opin. Struct. Biol. 9 1999 722 731
19. K. Iwai, K. Yamanaka, T. Kamura, N. Minato, R.C. Conaway, J.W. Conaway, R.D. Klausner, and A. Pause Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex Proc. Natl. Acad. Sci. U. S. A. 96 1999 12436 12441
20. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
21. O. Elroy-Stein, and B. Moss Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system J.E. Coligan B.M. Dunn H.L. Ploegh D.W. Speicher P.T. Wingfield Current Protocols in Protein Science 1998 John Wiley and Sons 5.15.1 5.15.11
22. F. Samaniego, J. Chin, K. Iwai, T.A. Rouault, and R.D. Klausner Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2 J. Biol. Chem. 269 1994 30904 30910
23. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. Chau, and W.G. Kaelin Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat. Cell Biol. 2 2000 423 427
24. K. Yamanaka, H. Ishikawa, Y. Megumi, F. Tokunaga, M. Kanie, T.A. Rouault, I. Morishima, N. Minato, K. Ishimori, and K. Iwai Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2 Nat. Cell Biol. 5 2003 336 340
25. M.E. Cockman, N. Masson, D.R. Mole, P. Jaakkola, G.W. Chang, S.C. Clifford, E.R. Maher, C.W. Pugh, P.J. Ratcliffe, and P.H. Maxwell Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J. Biol. Chem. 275 2000 25733 25741